If the cancer cells express LAIR1, as in acute myeloid leukemia, agonism is more likely to be effective, as demonstrated by a LAIR1 agonist antibody that induced cell death in leukemia stem cells in cell and xenograft models (17). Here, LAIR1 is linked to cancer.